NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Company watch » TOP 50 Pharmas » Pfizer back to previous page show list
Pfizer »09/06/2008 [Company watch]
Pfizer to acquire Tianjin Tianyao Pharmaceutical

Chinese media reports that pharmaceutical giant Pfizer is negotiating with Tianjin Tianyao Pharmaceutical (SHA: 600488) for possible acquisition of the company. Tianjin Tianyao Pharmaceuticals is China's biggest manufacturer of Glucocorticoid APIs and second only to Pfizer in world production. Tianyao generated revenues of RMB 698.9 million in 2007, and reported net income of RMB 26 million, a decrease of 42% compared with the same period in 2006. The company is regarded as an industry leader in China. The Tianjin municipal government, which is trying to build a pharmaceutical park, has welcomed Pfizer into the city.


AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.